# Colorcon

> Colorcon is a VC fund in Harleysville backing Health Care and Biotechnology. See 2 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Harleysville, United States
- Total investments: 2
- Last investment: Jun 2023
- Lead investor: 0%
- Last fund: Sep 2019
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/colorcon
- X (Twitter): https://twitter.com/colorcon
- Website: http://www.colorcon.com/

Colorcon is a company that specializes in the design and development of specialty excipients for solid oral dosages for the pharmaceutical and nutritional industries.

## Contacts

5 contacts available for Colorcon. Shizune tracks 2 team members at Colorcon. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/colorcon?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 100% |
| Biotechnology | 2 | 100% |
| Medical | 1 | 50% |
| Nutrition | 1 | 50% |
| Life Science | 1 | 50% |

9 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 50% |
| Series B | 1 | 50% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Kelly Boyer | Executive | 3 | https://shizune.co/investors/profile/kelly-boyer-470f |
| Simon Tasker | CEO | 0 | https://shizune.co/investors/profile/simon-tasker-21e9 |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| MEND | MEND is a life sciences company with a mission to help people heal and live their healthiest. The company is currently researching and developing targeted clinical nutrition and medical food interventions to enhance patient outcomes, from injury and surgery to aging and physical performance. MEND has been adopted by numerous hospitals, healthsystems, professional sports teams across all major leagues, and the elite forces of the US Military. The company is headquartered in New York City. | $16.5M | Series A | Jun 06, 2023 |  |
| Numerion Labs | Atomwise is a preclinical pharma company revolutionizing how drugs are discovered with AI. We invented the use of deep learning for structure-based drug discovery, today developing a pipeline of small-molecule drug candidates advancing into preclinical studies. Our AtomNet® technology has been used to unlock more undruggable targets than any otherAI drug discovery platform. We are tackling over 600 unique disease targets with more than 250 partners around the world, including leading pharmaceutical, agrochemical, and emerging biotechnology companies. Atomwise has raised over $174 million from leading venture capital firms to advance our mission to make better medicines, faster. Learn more at atomwise.com, or connect on Twitter and LinkedIn. | $123M | Series B | Aug 11, 2020 |  |

2 of 2 investments shown.

## Co-investors
- [Cerity Partners Ventures](https://shizune.co/investors/profile/touchdown-ventures) — VC Fund, 2 deals together
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund, 1 deal together
- [Baidu Ventures](https://shizune.co/investors/profile/baidu-ventures) — VC Fund, 1 deal together
- [B Capital](https://shizune.co/investors/profile/b-capital-group) — VC Fund, 1 deal together
- [Colorcon Ventures](https://shizune.co/investors/profile/colorcon-ventures) — VC Fund, 1 deal together
- [DCVC](https://shizune.co/investors/profile/data-collective) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Colorcon invest in?

Colorcon invests primarily in Health Care, Biotechnology and Medical startups, most often at Series A and Series B stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Colorcon?

Public channels for Colorcon include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Colorcon?

The team at Colorcon includes Kelly Boyer (Executive) and Simon Tasker (CEO). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co